Form 4: Eikon Therapeutics Insider Buys Shares
Insider Transaction (Form 4)
Column Group IV GP, LP and 7 others reported changes in beneficial ownership of Eikon Therapeutics, Inc. common stock on September 3, 2026.
Summary
- Open-market purchase: acquired 89,200 Common Stock at $11.56 ($1,031,045) on September 3, 2026; holds 89,200 after (Indirect).
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $1,031,045, committing personal capital to the stock.
Insider Transactions
Column Group IV GP, LP ā 10% owner
Column Group IV-A, LP ā 10% owner
Column Group IV, LP ā 10% owner
Column Group Opportunity III, LP ā 10% owner
Column Group Opportunity III GP, LP ā 10% owner
TCG Opportunity III GP, LLC ā 10% owner
Tim Kutzkey ā 10% owner
Peter Svennilson ā 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-03 | Open-market purchase | Common Stock | 89,200 | $12 | $1.0M | 89,200 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-03 | Open-market purchase (89,200 shares) |
Keywords
insider transaction, Form 4, EIKN, Eikon Therapeutics, Inc., bullish, Column Group IV GP, LP, Column Group IV-A, LP, Column Group IV, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Tim Kutzkey, Peter Svennilson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.